Qiagen (QGEN) Reports In-Line Q2 EPS; offers outlook

Qiagen (NYSE: QGEN) reported Q2 EPS of $0.60, in-line with the analyst estimate of $0.60. Revenue for the quarter came in at $534 million versus the consensus estimate of $523.87 million.

OUTLOOK

2025 net sales outlook increased to +4-5% CER (prior about +4% CER) and +5-6% CER core sales (prior about +5% CER); adj. diluted EPS outlook reaffirmed for about $2.35 CER

For earnings history and earnings-related data on Qiagen (QGEN) click here.

You May Also Be Interested In

• Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
• Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c
• H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)